Lilly's EloraTZP shows stronger weight-loss results than Zepbound
Eli Lilly reported stronger weight-loss results for experimental EloraTZP compared to tirzepatide alone. Shares of LLY traded down approximately 0.8%.
10pm ET on Thursday, October 1. The valuation picture shows shares 2…